Global Lenalidomide Market Share

Statistics for the 2023 & 2024 Global Lenalidomide market share, created by Mordor Intelligence™ Industry Reports. Global Lenalidomide share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Lenalidomide Industry

The Lenalidomide market is moderately competitive, with several players across the globe. In terms of market share, various major players currently dominate the market. With the rising treatment facilities and high prevalence of diseases, some regional players are expected to be part of the Lenalidomide market over the forecast period. The key players in the market of Lenalidomide are Sandoz, Delphis Pharma, Celgene Corporation, Dr. Reddy's Laboratories, Teva Pharmaceuticals, Cipla, Reliance Life Sciences, and Hetero Healthcare, Synthon, Deva.

Lenalidomide Market Leaders

  1. Sandoz

  2. Dr. Reddy’s Laboratories 

  3. BRISTOL-MYERS SQUIBB COMPANY (Celgene)

  4. Teva Pharmaceuticals 

  5. Cipla

*Disclaimer: Major Players sorted in no particular order

Allscripts Healthcare Solutions Inc., Koninklijke Philips N.V., OTH.IO, International business Machinery Corporation (IBM), and AMD Global Telemedicine Inc.

Lenalidomide Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)